TRi-1
TRi-1 is a potent, specific and irreversible inhibitor of cytosolic thioredoxin reductase 1 (TXNRD1), with an IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy[1].
Product Specifications
CAS Number
246020-68-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tri-1.html
Concentration
10mM
Purity
99.91
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=[N+](C1=CC=C(OC)N=C1S(=O)(C2=CC=C(Cl)C=C2)=O)[O-]
Molecular Formula
C12H9ClN2O5S
Molecular Weight
328.73
Precautions
H302, H315, H319, H335
References & Citations
[1]Stafford WC, et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018 Feb 14;10 (428) . pii: eaaf7444.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PA2070-carrier-free 100 µg/Vial
Anti-ADAM19 Antibody Picoband®, Carrier-free
Sign In for Pricing
View Details 
MBS6346489-01 0.1 mL
SETD4, NT (SETD4, C21orf18, C21orf27, SET domain-containing protein 4) (MaxLight 550)
Sign In for Pricing
View Details MBS6346489-02 5x 0.1 mL
SETD4, NT (SETD4, C21orf18, C21orf27, SET domain-containing protein 4) (MaxLight 550)
Sign In for Pricing
View Details 